Trademark: 97558711
Word
EYE2O
Status Date
Tuesday, September 17, 2024
Filing Date
Monday, August 22, 2022
Published for Opposition
Tuesday, September 17, 2024
5 Pharmaceutical preparations for the prevention and treatment of ophthalmic diseases; pharmaceutical preparations for the treatment of ophthalmic conditions; eye drops; artificial tears
The mark consists of the word "EYE" followed by a subscript "2" and a capital "O".
Color is not claimed as a feature of the mark.
Sep 21, 2022
Teas Voluntary Amendment Received
Sep 12, 2022
New Application Office Supplied Data Entered
Nov 4, 2022
Assigned To Lie
Nov 4, 2022
Preliminary/Voluntary Amendment - Entered
Jun 8, 2023
Assigned To Examiner
Jun 16, 2023
Suspension Letter Written
Jun 16, 2023
Letter Of Suspension E-Mailed
Jun 16, 2023
Notification Of Letter Of Suspension E-Mailed
Jan 17, 2024
Suspension Checked - To Attorney For Action
Mar 7, 2024
Suspension Inquiry Written
Mar 7, 2024
Inquiry To Suspension E-Mailed
Mar 7, 2024
Notification Of Inquiry As To Suspension E-Mailed
Apr 15, 2024
Teas Response To Suspension Inquiry Received
Apr 15, 2024
Correspondence Received In Law Office
Apr 15, 2024
Teas/Email Correspondence Entered
Apr 26, 2024
Letter Of Suspension E-Mailed
Apr 26, 2024
Suspension Letter Written
Apr 26, 2024
Notification Of Letter Of Suspension E-Mailed
Jul 18, 2024
Correspondence Received In Law Office
Jul 17, 2024
Teas Response To Suspension Inquiry Received
Jul 18, 2024
Teas/Email Correspondence Entered
Aug 12, 2024
Approved For Pub - Principal Register
Aug 28, 2024
Notification Of Notice Of Publication E-Mailed
Sep 17, 2024
Published For Opposition
Sep 17, 2024
Official Gazette Publication Confirmation E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
